Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombin: implications for intratumor therapy against metastasis.

A V D'Amico1, A C Nelson, R K Babayan

  • 1Bioengineering, University of Washington, Seattle 98195.

Journal of Cancer Research and Clinical Oncology
|January 1, 1988
PubMed
Summary

Intratumor injection of thrombin significantly increased longevity in rat cancer models. Thrombin therapy extended survival by approximately 85% compared to controls, showing promise as a cancer therapeutic agent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High hyaluronan binding and RHAMM expression identify an invasive and metastatic subpopulation in androgen-resistant prostate cancer cells.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same author

Determining optimal eluter design by modeling physical dose enhancement in brachytherapy.

Medical physics·2018
Same author

The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer.

Prostate cancer and prostatic diseases·2017
Same author

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death.

Prostate cancer and prostatic diseases·2016
Same author

Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression.

Oncogene·2016
Same author

Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.

Prostate cancer and prostatic diseases·2015

Area of Science:

  • Oncology
  • Biomedical Research
  • Translational Medicine

Background:

  • Solid tumors pose significant therapeutic challenges.
  • Cancer metastasis, particularly to the lungs, is a primary cause of mortality.
  • Novel therapeutic strategies are needed to improve patient survival and outcomes.

Purpose of the Study:

  • To evaluate thrombin as a potential intratumoral cancer therapeutic agent.
  • To assess the effect of thrombin injection on tumor growth and animal survival.
  • To investigate thrombin's impact on metastasis in preclinical cancer models.

Main Methods:

  • Two transplantable solid tumor models were used: renal adenocarcinoma in Wistar-Lewis rats and rhabdomyosarcoma in Wag-Rij rats.
  • Thrombin was administered as a single intratumor injection 6 weeks post-implantation.

Related Experiment Videos

  • Control groups received saline injections or no injection, with all groups handled identically.

    • Main Results:

    • Animals receiving thrombin showed significantly increased longevity compared to control groups.
    • Survival benefit was correlated with tumor size at the time of thrombin injection.
    • All animals, including those treated with thrombin, ultimately died due to verified pulmonary metastasis.

    Conclusions:

    • Intratumor thrombin injection demonstrated a substantial survival benefit in preclinical solid tumor models.
    • Thrombin therapy represents a promising approach for extending survival in cancer patients.
    • Further research is warranted to optimize thrombin-based cancer therapies and understand underlying mechanisms.